chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a nurse and refers to a 5-month-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. On 14-NOV-2017, the patient was vaccinated with PNEUMOVAX 23 intramuscularly, lot # N014946 with expiration date on 01-FEB-2017 (dose was unspecified) for prophylaxis, instead of scheduled PREVNAR 13. The reporter confirmed that that was an human error, not a product quality issue. No adverse effects were reported.
Patient reported redness to the R) arm with warmth and tenderness as well as fatigue2/20/19.  Sent message to provider with picture on 2/22/19. Provider recommended ice, rest, Tylenol for the discomfort, follow up with clinic if it worsens or a fever develops.
Breakthrough case admission after 4 vaccines Pfizer 2/11/21 Lot# EM9810;  Pfizer 3/48/21 Lot# EN6201;  Pfizer 10/9/21 Lot# FF2590;  Pfizer 1/7/23 Lot# GJ3274
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2022 at 9:52 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 13-Feb-2022 at 9:52 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 13-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Ethnicity of the patient was reported as EXACT.  Concomitant medication of the patient was not reported.  Vaccine administration time was given as 09:52:30. . No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869 (Patient Link).
Numbness from feet to hands, weakness in both hands, arms, feet and legs, throwing up, discoloration of skin, pain extremity throughout the whole body, numbness in both sides of the back, respiratory issues, Guillain Barre Syndrome symptoms, headache.
pt recv vax RA got lump @ site & red warm area size of half dollor-no temp;
Information has been received from a 50 year old female registered nurse with hypothyroidism and allergy to non-steroidal anti-inflammatory medications, who on 08-JAN-2008 was vaccinated with a first dose of RECOMBIVAX HB, 1 ml intramuscularly.  On 28-FEB-2008 was vaccinated with a second dose of RECOMBIVAX HB (Lot # 656879/1148U) and on 02-JUL-2008 was vaccinated with a third dose of RECOMBIVAX HB (Lot # 660951/0398X).  Concomitant therapy included SYNTHROID and TAPAZOLE.  On 13-JUL-2008 the patient developed chest discomfort on inspiration and low-grade fever.  On 20-JUL-2008, she was examined in a local emergency room and had an electrocardiogram, chest X-ray, unspecified blood work, and computerized tomography of the chest.  A diagnosis of pericarditis was made, and the patient was prescribed a four day course of prednosone 40 mg daily.  The symptoms resolved.  On 29-JUL-2008 the chest discomfort returned and the patient was scheduled to see her physician.  There was no product quality complaint.  No further information is available.
Chickenpox declared on 7/25/2000; cellulitis began on 07/27/2000; hospitalization and surgery on 7/28/2000. Cellulitis involved the right labia. No other vaccines given 7/24/00. Per F/U 7/2/02: Incision and drainage of right libia abscess. She was then started on Ancef and clindamycin IV. The pt had temperature on 2nd day of hospitalization and required IV antibiotics until she was afebrile. Had a 3 day history of temperature of 102F-103F. Had been seen and started on Keflex 1 day prior to admission.
local swelling, warmth, tenderness lasting for 3mo w/gradual resolution, rash urticarial tender to palpations deltoid lasting 3days in AUG97;migratory arthralgia devel AUG97 affecting all joints;
cyst under the left armpit; Small swelling in her left arm pit,swelling in both her arm pits; This spontaneous case was reported by a consumer and describes the occurrence of CYST (cyst under the left armpit) and PERIPHERAL SWELLING (Small swelling in her left arm pit,swelling in both her arm pits) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus (type one insulin dependent diabetic for fifty years this December).   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PERIPHERAL SWELLING (Small swelling in her left arm pit,swelling in both her arm pits). On an unknown date, the patient experienced CYST (cyst under the left armpit). On 22-Mar-2021, PERIPHERAL SWELLING (Small swelling in her left arm pit,swelling in both her arm pits) had resolved. At the time of the report, CYST (cyst under the left armpit) outcome was unknown.            No concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-102335 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: significant-event added
Receiving a dose from a vial that was opened more than 12hs before vaccination; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Receiving a dose from a vial that was opened more than 12hs before vaccination) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Receiving a dose from a vial that was opened more than 12hs before vaccination). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Receiving a dose from a vial that was opened more than 12hs before vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Following vaccination patients showed no symptoms was noted. The reporter stated that the vial was first opened yesterday at 9:20 am. Concomitant was not provided by the reporter. No treatment information was provided by the reporter.
Usual 2 - 3 days of feeling like I had a flu shot. Then starting on day 4 extreme diarrhea and exacerbated joint pain.  All symptoms continue to date.
Developed shortness of breath, chest pain, very high Blood pressure, Pericarditis. In able to work. Hospitalised. On medication.timeframe unknown.
I have been so sick from the 1st dose; This is a spontaneous report from a non-contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient has been so sick from the 1st dose  on an unspecified date. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
hyperthermia, tachycardia, chills, malaise, anxiety, sensitive skin/nerves, muscle and joint aches/pains.
looking flush and warm; not feeling well; vomited; This spontaneous report has been received from a nurse via a company representative referring to an 18 years old female patient. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.      On 06-JUL-2020, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (1 dose; lot #, expiration date, route and dose details were unknown) for prophylaxis.         On 06-JUL-2020, after receiving the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), the patient "not feeling well", "looking flush and warm", then vomited. The patient was seen by nurse and no treatment was taken. The patient's symptoms recovered "after 5 to 10 minutes". The nurse also stated the patient did not eat prior to receiving the dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9).      The causality assessment between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.
Patient took a Rabies shot and the next day, reported this (brain tumor) event to us.
Patient felt funny after getting vaccination, I directed her to wait 30 minutes at the pharmacy. At the end of 30 minutes, she said she felt like she wanted to take a Benadryl tab that she had in her purse and she said that she had an Epipen as well. Her husband accompanied her and she said that she was going to leave. I counseled her to watch for signs of anaphylaxis and she left. After she left, on the drive home she felt like she was having trouble breathing, so she went the ER. At the ER they gave her some steroids and she felt better.
Pt recv vax on 11/5/98; on 11/7/98 pt exp cellulitis at vax site w/ maculopapular rash; tx=Augmentin
Arm turned red, painful and warm. Became progressively worse until day 4. Day 4 no improvement, but stayed the same. Patient believes it could be cellulitis . She is going to see her doctor, but hasn't yet.
LEGS LOOK RED; CHILLING EFFECT; PAINING IN LEG; FACE HAS RASH; FEVER; NAUSEA; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch or lot number. No concomitant medications were reported. On an unspecified date, the patient experienced legs look red, chilling effect, paining in leg, face has rash, fever, and nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chilling effect, fever, and nausea, and the outcome of paining in leg, legs look red and face has rash was not reported. This report was non-serious.
69 expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 expired doses administered). On 10-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Treatment medication were not reported.
upset stomach; This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On 18th September 2020, the patient received Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. On 21st September 2020, 3 days after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced upset stomach. On an unknown date, the outcome of the upset stomach was not recovered/not resolved.   It was unknown if the reporter considered the upset stomach to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were as follows: The case was reported by the wife for her husband. After receiving dose of Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced upset stomach. The reporter reported that, could it be from the vaccine. The reporter wanted to know how long after a Shingrix vaccine side effects could take place. The reporter consented to follow.
2cm local rxn-mild erythema, swelling, induration, tenderness-48hr post vax;
3 days after my dose 2 vaccine, I literally ran into my wall because I was so dizzy. I had trouble hearing and why I had already had some hearing loss being 70 years old, especially the left ear was almost total loss of hearing at this time now later I now have a hearing aide in both ears. One of the other symptoms was a very dry hacking cough that comes out of your throat makes me gag and cough like crazy, immediately thereafter almost simultaneously will change into a cough into runny nose and sneezing fits. I have nausea day and night just out of the blue. There is very little I can do to make it better; I have tried different things and nothing helps. Along with the dizziness which is essentially in my head I have very difficult problems walking, when I try to walk, I have to make sure I have a cane with me to help me. One of the other side effects are the brain fog quite often the words I am trying to say won't come out. I have to put words in my tablet to use so I can talk to someone. The latest problem that I have that I did not immediately realize was a problem is that I wore glasses but could go without them and now my doctor has sent me to an eye doctor and I began noticing that all of a sudden that my eyes are getting dryer and dryer. I am constantly using eye drops to moisten my eyes. I am at the point that my regular eye doctor is unable to help me and he sent me to an eye dry specialist. Right now I am on steroid drops and we started that last Saturday and my right upper half of my face was swollen and I did have pink whelps over my face. I am hoping that we can repair that the drops can do the trick or otherwise I will have to find between $4000-$8000 to have a amniotic tissue transplant to help with the dry eyes. All of this I did not recognize as a vaccination side effect.
MUSCLE ACHES; FATIGUE; This spontaneous report received from a patient concerned a 70 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: 23-JUN-2021) dose was not reported, administered on 22-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 23-MAY-2021, the subject experienced muscle aches. On 23-MAY-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from muscle aches, and fatigue. This report was non-serious.
Temp 100'F nausea, vomiting, uncontrollable shivering, diarrhea, severe malaise which lasted 12 hrs. (L) arm (upper) severe Raised & tender and Red lasting 3 days.
The volunteer chose a landing mark for the needle which when stuck into my shoulder joint area, hit something, so he immediately withdrew that needle.  He then took a new second needle and chose a 2nd landing mark that was close to the first needle "stick" and delivered the vaccine.  I felt immediate burning  and that continued for much of the day.   The burning proceeded into intense pain.  I returned to the Senior Center at 7:30 a.m. the next morning and reported the error the volunteer made and showed the head nurse the bruise that was high - at my upper arm - and nearly on my shoulder.  The head nurse said it was "high."   She asked me what I wanted her to do.  I responded that she should report the error and I would like it documented, as I was now afraid I might have endured a shoulder/joint injury.  I also called the health department and the Covid-19 Help Line  and reported the error.  I had two days of intense pain, where I could not physically, not just the excruciating pain, lift my arm.  I emailed an Orthopaedic doctor who specialized in shoulders and made an emergency apmt with him.  I also made an apmt with my primary.  My ortho doctor is treating me for SIVRA, I am on anti-inflammatories, I am having physical therapy on my left shoulder, as there is constant pain.  I am scheduled for return visits to my orthopaedic doctor and this appears to be a concern as far as damage, time course and outcome.  I hope the head nurse DID report the injury to my shoulder area.  She promised to record the event in "my file,"
PFIZER COVID VACCINE #3 GIVEN 9/29/21, LOT #301558A; pt in SNF, for severe end-stage Parkinson's disease; positive for COVID test on 1/31/22; dx with COVID pneumonia; pt status DNR-C; MD has been signing off on pt in the facility; transitioned to hospice; pt passed away in the facility on hospice
Narrative: Patient COVID positive despite 3 doses of vaccine. Admitted 4/27 - 4/28
feel really sick on same day; little tired from work; Nausea; Vomiting; Hot flash; Fever of 101.5 degrees Fahrenheit; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (Hot flash), PYREXIA (Fever of 101.5 degrees Fahrenheit), NAUSEA (Nausea), VOMITING (Vomiting) and MALAISE (feel really sick on same day) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. Unknown and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     NO INFORMATION WAS ADDED.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced HOT FLUSH (Hot flash) and PYREXIA (Fever of 101.5 degrees Fahrenheit). On 20-May-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomiting). On an unknown date, the patient experienced MALAISE (feel really sick on same day) and FATIGUE (little tired from work). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. On 20-May-2021, HOT FLUSH (Hot flash) and PYREXIA (Fever of 101.5 degrees Fahrenheit) had resolved. On 21-May-2021, NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. At the time of the report, MALAISE (feel really sick on same day) and FATIGUE (little tired from work) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   NO CONCOMITANT AND TREATMENT MEDICATION WERE USED   This case was linked to MOD-2021-162407 (Patient Link).
Warmth, slight pain at injection site. Early in the evening developed fatigue, stiffness, muscle ache, felt feverish. Symptoms increased in the night. Short episode of "chills" (uncontrolled shivering without actually being cold) in the night.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 16-FEB-2017 at 16:53, the patient was vaccinated with improperly stored VARIVAX injection (lot # M018436) ( expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA008441:  US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000473: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704U.